15 Feb 2017 --- DSM have announced strong results for 2016, well ahead of strategic goals. Sales were up 3% to €7,920m ($8,362m), with 4% organic growth. Adjusted EBITDA up 17% to €1,262m ($1,331m), ROCE up 280 bps to 10.4% driven by 38% increase in Adjusted EBIT. Cash from operating activities were up 27% to €1,018m ($,1074m), and a reported net profit of €629m ($663m) compared to €92m in 2015.
